DALLAS: In this study researchers are taking about 20 healthy persons with the Alzheimer’s gene and administering a specially-designed drug.
It is part of a drug trial involving more than 200 people around the world.
The drug, which cannot be named because it is still being trialled, targets the build-up of amyloids in the brain.
These build-ups form plaques which are thought to cause the damage that ultimately leads to Alzheimer’s.
It is hoped the drugs will bind to the amyloids and be flushed from the brain, and Alzheimer’s will not develop.
Using high-tech scans, researchers will compare the damage occurring in the brain over time through Alzheimer’s to what a healthy brain looks like…